Results 251 to 260 of about 945,743 (288)
Some of the next articles are maybe not open access.
Adenylate kinase 2, a mitochondrial enzyme
Biochemical Genetics, 1977The subcellular compartmentalization of the isoenzymes of ATP:AMP phosphotransferase (adenylate kinase) was analyzed in HeLa cells, RAG cells, and RAG-human hybrids that express human AK-2. In HeLa cells and in the hybrids, human AK-2 was present in a mitochemical fraction prepared from cell extracts and in mitochondria purified by density gradient ...
V.M. Regina, Gail A. P. Bruns
openaire +3 more sources
ERYTHROCYTE ADENYLATE-KINASE DEFICIENCY
The Lancet, 1969Slava Gavendo+2 more
openaire +3 more sources
Adenylate kinase as a marker for platelet lysis
Transfusion, 1990The level of extracellular lactate dehydrogenase (LDH) activity is often used as an indicator for the leakage of cytosolic platelet contents. The objective of this investigation was to study the possibility of using a different enzyme, adenylate kinase (AK), as a substitute for LDH.
openaire +3 more sources
Properties of human hepatoma adenylate kinases
International Journal of Biochemistry, 1978Abstract 1. 1. Three adenylate kinase isoenzymes, designated AK I, II and III in order of their increasing electrophoretic mobility towards the anode were partially purified from human hepatomas. 2. 2. When AK III was passed through phosphocellulose, multiple forms were again obtained. 3. 3.
openaire +3 more sources
Characteristics in limbic encephalitis with anti–adenylate kinase 5 autoantibodies
Neurology, 2017L. Do+18 more
semanticscholar +1 more source
ADENYLATE KINASE IN NEUROLOGICAL DISEASES
The Lancet, 1979JohanA. Aarli+4 more
openaire +3 more sources
Trends in kinase drug discovery: targets, indications and inhibitor design
Nature Reviews Drug Discovery, 2021Helgi B Schiöth+2 more
exaly
Kinase drug discovery 20 years after imatinib: progress and future directions
Nature Reviews Drug Discovery, 2021Darren Cross+2 more
exaly
Kinase inhibition in autoimmunity and inflammation
Nature Reviews Drug Discovery, 2021Ali A Zarrin+2 more
exaly